SCHEMBL4199387

SCHEMBL4199387

CC(=O)Nc1ccc(OC(=O)c2ccccc2)cc1OC[C@@](C)(O)CN(Cc1ccc(Cl)cc1)C1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.45
ABCB11 O95342 2/20 0.45
BRD4 O60885 8/20 0.40
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
SLC6A2 P23975 4/20 0.33
SLC6A4 P31645 4/20 0.33
SLC6A3 Q01959 2/20 0.33
PPARD Q03181 1/20 0.33
SSTR1 P30872 1/20 0.33
SSTR4 P31391 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL4199385 0.88 CCR1 (0.54) CCR1ABCB11BRD4KDM4CSLC6A2
SCHEMBL5583485 0.86 ABCB11 (0.58) CCR1ABCB11BRD4KMT2AALDH1A1
SCHEMBL7263208 0.86 ABCB11 (0.58) CCR1ABCB11BRD4KMT2AALDH1A1
SCHEMBL4199398 0.84 CCR1 (0.46) CCR1ABCB11BRD4KMT2AALDH1A1
SCHEMBL5583417 0.80 ABCB11 (0.48) CCR1ABCB11BRD4KMT2ASMN1; SMN2
SCHEMBL5583430 0.79 ABCB11 (0.48) CCR1ABCB11BRD4SLC6A2SLC6A4
SCHEMBL5583514 0.79 ABCB11 (0.48) CCR1ABCB11BRD4KMT2AALDH1A1
SCHEMBL2061810 0.78 ABCB11 (0.75) CCR1ABCB11KMT2AALDH1A1GAA
SCHEMBL5583496 0.78 ABCB11 (0.46) CCR1ABCB11BRD4KMT2ASMN1; SMN2
SCHEMBL28253627 0.69 KMT2A (0.54) BRD4KMT2AALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027105-A2 NOVEL PROCESS FOR PREPARING INTERMEDIATES OF CCR ANTAGONISTS AstraZeneca AB (SE) 2009-02-25 EP disclosed
WO-2007129960-A2 NOVEL PROCESSES FOR PREPARING INTERMEDIATES OF CCR ANTAGONISTS ASTRAZENECA AB (SE) 2007-11-15 WO disclosed